In Woodcliff Lake, New Jersey, on October 30, 2025, Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) disclosed that its Board of Directors has approved an extension of the existing limited duration stockholder rights plan (now amended as the "Rights Plan") by one year. The amendment sets the plan duration until October 30, 2026, and is now in effect.